Helixate News and Research

RSS
CSL Behring offers new dosage strength of Helixate FS in U.S.

CSL Behring offers new dosage strength of Helixate FS in U.S.

Ipsen Group announces first-half 2009 financial results

Ipsen Group announces first-half 2009 financial results

FDA approves Helixate FS for routine prophylaxis in children with hemophilia A

FDA approves Helixate FS for routine prophylaxis in children with hemophilia A